Understanding Multiple News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Understanding Multiple. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Understanding Multiple Today - Breaking & Trending Today

AbbVie Presents Results from Phase 3 CANOVA Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma

Published: October 2, 2023

AbbVie (NYSE: ABBV) today announced data from its Phase 3 CANOVA study evaluating the safety and efficacy of venetoclax (VENCLEXTA®/ VENCLYXTO®) plus dexamethasone (VenDex) for patients with t(11;14)-positive relapsed or refractory (R/R) multiple myeloma who have received two or more prior treatments. Data did not ...

Source: pharmiweb.com

Related Topics:

United KingdomRheinland PfalzMariana Cota StirnerVenclyxto SmExchange CommissionInternational Myeloma Society Annual MeetingAbbvie Deutschland Gmbh CoInternational Myeloma Working GroupBlood Cancer Press KitRoche GroupMyeloma Research FoundationInternational Myeloma FoundationAllergan AestheticsPrivate Securities Litigation Reform ActQuarterly ReportsDexamethasone Compared With PomalidomideSubjects With RelapsedRefractory Multiple MyelomaMyeloma ResearchUnderstanding MultipleMultiple MyelomaProduct CharacteristicsAbbvie Deutschland Gmbh